← All recalls

Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

CPSC · 23154 · published 2023-03-16

CPSC campaign 23154

Hazard

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Remedy

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

The text above is quoted verbatim from the CPSC record. Confirm the affected units and the remedy with the manufacturer or CPSC. Recall data may be incomplete, delayed, or superseded.

Own something like this?

Track your items and we’ll tell you the moment a recall covers one — free, forever.

Track an item like this

Affected products

Biohaven Pharmaceuticals Inc., of New Haven, Conn.

Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack

Brands in this recall